i
This Document Has Been Replaced By: Prevention of varicella; recommendations of the Advisory Committee on Immunization Practices (ACIP)
Superseded
This Document Has Been Replaced By: Prevention of varicella; recommendations of the Advisory Committee on Immunization Practices (ACIP)
Prevention of varicella; recommendations of the Advisory Committee on Immunization Practices
-
July 12, 1996
-
Details:
-
Personal Author:
-
Corporate Authors:
-
Description:"These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of live, attenuated varicella virus vaccine--VARIVAX--manufactured by Merck and Company, Inc. and licensed in March 1995 for use in healthy persons > or = 12 months of age. In addition to presenting information regarding vaccine, this statement updates previous recommendations concerning the use of varicella zoster immune globulin (VZIG) as prophylaxis against varicella (MMWR 1984; 33:84-90, 95-100)." - p. 1
-
Content Notes:"The following CDC staff members prepared this report: Sandra J. Holmes, Susan Reef, Stephen C. Hadler, Walter W. Williams, Melinda Wharton, Epidemiology and Surveillance Division, National Immunization Program." - p. iv
Also available via the World Wide Web.
Includes bibliographical references (p. 32-36.)
-
Subjects:
-
Series:
-
Pubmed ID:8668119
-
Document Type:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: